NCT05069831View on ClinicalTrials.gov

JAK Inhibition in Food Allergy

PHASE1CompletedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

June 13, 2025

Study Completion Date

June 13, 2025

Conditions

Food Allergy

Interventions

DRUG

Abrocitinib

Abrocitinib daily for 4 months

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors

lead

Icahn School of Medicine at Mount Sinai

OTHER